Screener
Ligand Pharmaceuticals LGND Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's price / book?
- Ligand Pharmaceuticals (LGND) reported price / book of 6.5× in Q2 2026.
- How has Ligand Pharmaceuticals's price / book changed year-over-year?
- Ligand Pharmaceuticals's price / book increased by 137.5% year-over-year, from 2.8× to 6.5×.
- What is the long-term trend for Ligand Pharmaceuticals's price / book?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's price / book has grown at a 9.3% compound annual growth rate (CAGR), from 2.3× to 3.7×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Ligand Pharmaceuticals's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude